The information in this article is just part of the entire discussion and you will be asked to register (free) after accessing 6 articles. It's worth it imo. This particular article deals briefly with current therapies, RAV's, cirrhosis, transplantation, etc., from 4 experts in the field . I recommend you review the site, as it offers a look into our world (HCV) and the newest considerations on treatment.
"The 2015 International Liver Congress celebrated its 50th anniversary by featuring some of the most up-to-date findings in the rapidly evolving field of hepatitis C virus therapies. More than 10,000 attendees gathered in Vienna, Austria, from April 22 to 26 to hear research on the latest pangenotypic direct-acting antiviral therapies emerging in the field as well as commentary on underserved populations finding higher cure rates than ever."
The information in this article is just part of the entire discussion and you will be asked to register (free) after accessing 6 articles. It's worth it imo. This particular article deals briefly with current therapies, RAV's, cirrhosis, transplantation, etc., from 4 experts in the field . I recommend you review the site, as it offers a look into our world (HCV) and the newest considerations on treatment.
"The 2015 International Liver Congress celebrated its 50th anniversary by featuring some of the most up-to-date findings in the rapidly evolving field of hepatitis C virus therapies. More than 10,000 attendees gathered in Vienna, Austria, from April 22 to 26 to hear research on the latest pangenotypic direct-acting antiviral therapies emerging in the field as well as commentary on underserved populations finding higher cure rates than ever."
2015 ILC Conference, Austria